London, UK. February 27, 2015
Melasma: the role of priming agents to avoid post inflammatory hyperpigmentation
Melasma is one of the most common dermatologic disorder. In spite of tremendous research, the treatment remains frustrating both to the patient and to the treating physician. Melasma is chronic and relapsing, patients are inherently embarrassed by hyperpigmentation, sometimes avoiding public exposure and personal relationships.
The combination of topical bleaching therapies and series of chemical peels proves to be a promising modality for the treatment of melasma. Sun avoidance and sun protection are also of primary importance in melasma management.
The biggest drawback with the use of bleaching and peel agents for melasma in sensitive skins and dark phototypes is Post Inflammatory Hyperpigmentation, which can either occur between the treatment sessions or after stopping treatment.
Priming or preparing the skin prior to the peel is an essential adjunctive measure, which also enhances the effect of the peeling agent apart from decreasing the Post Inflammatory Hyperpigmentation. It involves the application of a blend of Alpha Hydroxyacids in lower concentration 2-3 weeks prior to the planned day of the in office depigmentation treatment, and between different peel sessions.
Several studies asses the benefit of priming agents as adjuncts to chemical peels. Priming ensures uniform penetration of the peeling agent, enhances healing, detects intolerance to any agent and maintains the effects achieved with the chemical peel.
md:ceuticals proposes two different effective priming solutions, depending on skin type and specific problem to be treated:
- md:prepeel AHAs complex 15% combines the effects of Glycolic acid, Lactic acid, Hyaluronic acid and the Antioxidant Complex to cause gradual skin exfoliation enhancing the effects of later in-office peel and other facial treatments, revealing a healthier, brighter and younger skin complexion.
- In case of oily, acne-prone and sensitive skins it is recommended the application of md:prepeel Beta&AHAs complex 8%. It combines the effects of a blend of Beta and Alpha Hydroxy acids, such as Salicylic, Lactic and Glycolic acid with the antioxidant and moisturizing power of the Hyaluronic acid to accelerate skin exfoliation enhancing the benefits of later in-office peel and revealing a younger skin free of imperfections, comedones and pores.
Although the treatment of melasma in dark and sensitive skin is both frustrating and challenging, cautious and judicious use of chemical peels with a few precautions offers great satisfaction to both the patient as well as the treating physician. A powerful priming & antioxidant solution will multiply the treatment benefits make them safer.
Press Contacts: md:ceuticals PR
md:ceuticals,the md:ceuticals logo, md:peel, md:complex, melanoceuticals and melan:off are trademarks of md:ceuticals. Other company and product names may be trademarks of their respective owners.